Insulet
PODD
#1429
Rank
โ‚น1.388 T
Marketcap
โ‚น19,730
Share price
-4.53%
Change (1 day)
-10.86%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2025 (TTM): โ‚น237.37 Billion

According to Insulet's latest financial reports the company's current revenue (TTM ) is โ‚น256.62 Billion. an increase over the revenue in the year 2024 that were of โ‚น177.71 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น243.11 B36.8%
2024 โ‚น177.71 B25.79%
2023 โ‚น141.28 B30.8%
2022 โ‚น108.01 B32.07%
2021 โ‚น81.78 B23.65%
2020 โ‚น66.14 B25.65%
2019 โ‚น52.64 B33.53%
2018 โ‚น39.42 B33.14%
2017 โ‚น29.61 B18.74%
2016 โ‚น24.93 B33.92%
2015 โ‚น18.62 B1.76%
2014 โ‚น18.29 B19.87%
2013 โ‚น15.26 B31.9%
2012 โ‚น11.57 B43.69%
2011 โ‚น8.05 B85.37%
2010 โ‚น4.34 B41.81%
2009 โ‚น3.06 B76.78%
2008 โ‚น1.73 B230.26%
2007 โ‚น0.52 B203.12%
2006 โ‚น0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.925 T 3,378.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น4.200 T 1,536.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น3.362 T 1,210.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
โ‚น6.176 T 2,306.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
โ‚น95.42 B-62.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
โ‚น211.42 B-17.61%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚น441.75 B 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA